n-methyladenosine has been researched along with Lung Neoplasms in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (11.11) | 24.3611 |
2020's | 40 (88.89) | 2.80 |
Authors | Studies |
---|---|
Li, Q; Wang, C; Xiong, Y; Yang, X; Zhang, D; Zhang, R | 1 |
Guo, M; Li, Z; Ming, L; Qin, Z; Wan, J; Wang, Y; Yang, Z; Zhao, Z; Zheng, J | 1 |
Gao, S; He, J; Luo, Y; Sun, N; Tan, F; Wang, L; Wu, P; Xue, L; Xue, Q; Yang, Z; Zeng, H; Zeng, Q; Zhang, C; Zhang, G; Zhang, Z; Zheng, B | 1 |
Chen, YM; Chien, CS; Chien, Y; Chiou, SH; Hsiao, YJ; Hsu, PK; Liang, Y; Lin, TW; Lin, TY; Luo, YH; Teng, PC; Teng, YC; Wang, ML; Yang, YP; Yarmishyn, AA | 1 |
Bai, Z; Wu, X | 1 |
He, J; Luo, Y; Sun, N; Wang, L; Wu, P; Xue, Q; Yang, Z; Zeng, Q; Zhang, C; Zhang, G; Zhang, Y; Zhang, Z | 1 |
Bao, F; Chu, X; Feng, L; Sun, Z; Wang, W | 1 |
Dong, Z; Feng, W; Gao, M; Han, J; Huang, H; Huang, J; Kloeber, JA; Liu, S; Lou, Z; Qi, Z; Xu, M; Xu, Z | 1 |
Chen, B; Hu, Z; Zhang, Y; Zhu, L | 1 |
Ding, H; Gao, C; Kong, N; Li, J; Sun, Z; Tang, T; Wu, L; Xu, M; Zhang, F | 1 |
Huang, T; Ye, W | 1 |
Cui, Z; Guo, B; Jia, E; Ren, N; Xue, J; Zhang, B | 1 |
Dong, C; Fu, Z; Li, D; Song, Y | 1 |
Bai, L; Chen, Q; Hu, CP; Jiang, J; Li, YY; Wan, RJ; Zhang, Y; Zhao, BR | 1 |
Fan, J; Geng, W; Huang, Q; Jin, Y; Li, Y; Tan, Q; Xiao, W; Xu, J; Yang, G; Yin, Z | 1 |
Huang, Y; Ma, M; Wang, B; Wang, W; Yang, Y; Ye, L; Zhao, G | 1 |
Chen, Y; Liao, X; Ling, Q; Liu, C; Wu, S | 1 |
Cai, F; Fu, Y; Gai, Y; Ge, X; Qin, X; Shang, Y; Xiao, H; Xu, J; Zhou, C | 1 |
Chen, H; Hu, B; Lyu, Y; Qian, D; Shao, G; Yan, Q; Zhu, L | 1 |
Ge, H; Jin, L; Wang, N; Wang, X; Wang, Y; Wu, S; Xu, Y; Zhao, J; Zhou, F | 1 |
Bian, J; Bubenik, JL; Fernandez, P; Hiers, NM; Li, L; Li, T; Sheng, P; Swanson, MS; Traugot, CM; Wang, Y; Xie, M | 1 |
Jiang, W; Liu, H; Ma, X; Meng, Q; Wang, S; Xu, C; Zhou, S; Zhou, X | 1 |
Chao, Y; Ji, W; Shang, J | 1 |
Chen, L; Chen, Z; Deng, Q; Dinglin, X; Hou, X; Huang, H; Li, D; Ling, Y; Lv, Z; Ma, S; Peng, Y; Wang, H; Wu, Y | 1 |
Chen, J; Chen, Y; Lin, L; Xu, F; Zhang, H | 1 |
Chen, P; Ma, L; Qian, Q; Zhao, X; Zhu, Z | 1 |
Chen, F; Chen, Z; Li, J; Lin, X; Lv, Z; Peng, Y; Wang, H | 1 |
Hu, Q; Li, J; Liu, L; Liu, X; Sun, R; Zhang, Y | 1 |
Chen, JZ; Chen, WW; Hang, Y; Qi, JW; Wang, HH; Wang, J; Wu, JX; Zhou, XX | 1 |
Xie, Y; Zhao, W | 1 |
Feng, F; Gao, C; Li, H; Liu, C; Liu, L; Sun, C; Zhou, C; Zhuang, J | 1 |
Bu, P; Feng, Y; Guo, Y; Hu, X; Jiang, A; Li, D; Lin, Y; Liu, C; Liu, Y; Wang, X; Yan, H; Zhang, L; Zhang, S | 1 |
Ding, X; Li, D; Peng, Y; Wang, X; Wang, Y; Wu, Y; Yang, A; Yang, P; Yin, H; Yu, Y; Zhang, J; Zhang, R; Zhang, X | 1 |
Chang, N; Che, Y; Jiang, J; Qiao, T; Wu, B; Wu, Y; Xiong, J; Xu, L; Zhang, J; Zhang, X; Zhang, Y; Zhou, Y | 1 |
Cang, S; Jia, G; Ma, P; Song, Z | 1 |
Cheng, Y; Dong, H; Wang, M; Wang, S; Xu, H; Zhou, J | 1 |
Ning, J; Okon, I; Satyanarayana, G; Song, P; Xu, S; Zhang, D; Zheng, X; Zou, MH | 1 |
Chen, E; Dong, L; Jiang, C; Li, J; Li, X; Liu, P; Lu, B; Lu, Y; Qian, X; Qiu, Q; Yang, J; Ying, K | 1 |
He, X; Hu, K; Jin, M; Li, G; Liu, W; Song, Y; Wu, X; Xiong, M; Zeng, Z; Zhang, Q; Zhao, D; Zhu, J | 1 |
Chen, L; Lv, X; Ou-Yang, H; Ti, X; Wu, S; Xu, X; Zhang, Y; Zhao, F | 1 |
Huang, Z; Shi, J; Shi, M; Wang, J; Zhang, H; Zheng, M; Zhou, H; Zhou, Y | 1 |
Dai, H; Gu, S; Sun, D; Zhang, Z | 1 |
Du, Z; Jin, Y; Liu, J; Ren, D; Wang, H; Zhang, H | 1 |
Bley, N; Chen, J; Dahl, A; Fuchs, T; Glaß, M; Haase, J; Huang, H; Hüttelmaier, S; Lederer, M; Müller, S; Posern, G; Singh, AK | 1 |
Gao, Y; Han, Y; Jia, W; Li, B; Li, J; Qian, Z; Zhang, H; Zheng, H | 1 |
2 review(s) available for n-methyladenosine and Lung Neoplasms
Article | Year |
---|---|
RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.
Topics: Adenosine; Animals; Epigenesis, Genetic; Humans; Lung Diseases; Lung Neoplasms; RNA; RNA Processing, Post-Transcriptional; RNA, Long Noncoding; RNA, Messenger | 2021 |
The Important Role of N6-methyladenosine RNA Modification in Non-Small Cell Lung Cancer.
Topics: Adenosine; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Disease Progression; Drug Resistance, Neoplasm; Epigenesis, Genetic; Humans; Lung Neoplasms; Prognosis; RNA | 2021 |
1 trial(s) available for n-methyladenosine and Lung Neoplasms
Article | Year |
---|---|
Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification.
Topics: Adenocarcinoma of Lung; Adenosine; Ferroptosis; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Nomograms; Risk Assessment; RNA, Long Noncoding | 2022 |
42 other study(ies) available for n-methyladenosine and Lung Neoplasms
Article | Year |
---|---|
Gene and prognostic value of N6-methyladenosine (m6A) modification regulatory factors in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Humans; Lung Neoplasms; Methyltransferases; Prognosis | 2022 |
N-6 methylation-related lncRNA is potential signature in lung adenocarcinoma and influences tumor microenvironment.
Topics: Adenocarcinoma of Lung; Adenosine; Aged; Computational Biology; DNA Methylation; Female; Humans; Lung Neoplasms; Male; Middle Aged; RNA, Long Noncoding; Transcriptome; Tumor Microenvironment | 2021 |
The landscape of m
Topics: Adenosine; Biomarkers, Tumor; Computational Biology; Disease Susceptibility; Gene Expression Regulation, Neoplastic; Genetic Variation; Humans; Lung Neoplasms; Methylation; Prognosis; RNA; Signal Transduction; Small Cell Lung Carcinoma | 2021 |
Multi-omics analysis of m
Topics: Adenocarcinoma of Lung; Adenosine; Aged; Biomarkers, Tumor; CTLA-4 Antigen; Female; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Male; Prognosis; Tumor Microenvironment | 2021 |
m
Topics: Adenosine; Drug Resistance, Neoplasm; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Small Cell Lung Carcinoma | 2021 |
An N
Topics: Adenocarcinoma of Lung; Adenosine; Biomarkers, Tumor; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms | 2022 |
m6A demethylation of cytidine deaminase APOBEC3B mRNA orchestrates arsenic-induced mutagenesis.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Arsenic; Carcinoma, Non-Small-Cell Lung; Cytidine Deaminase; Demethylation; Humans; Lung Neoplasms; Minor Histocompatibility Antigens; Mutagenesis; RNA, Messenger | 2022 |
N6-methyladenosine-induced SVIL antisense RNA 1 restrains lung adenocarcinoma cell proliferation by destabilizing E2F1.
Topics: A549 Cells; Adenocarcinoma of Lung; Adenosine; Cell Proliferation; E2F1 Transcription Factor; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Membrane Proteins; Methyltransferases; Microfilament Proteins; RNA Stability; RNA, Antisense; RNA, Long Noncoding; Tumor Cells, Cultured | 2022 |
Correlation analysis of m6A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adenosine; Humans; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Methylation; RNA; RNA Processing, Post-Transcriptional; Tumor Microenvironment | 2022 |
Construction and validation of a novel prognostic model for lung squamous cell cancer based on N6-methyladenosine-related genes.
Topics: Adenosine; Biomarkers, Tumor; Epithelial Cells; Humans; Lung; Lung Neoplasms; Prognosis | 2022 |
Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribon
Topics: Adenosine; Animals; Carcinoma, Non-Small-Cell Lung; Catalytic Domain; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Humans; Lung Neoplasms; Methylation; Methyltransferases; Mice; RNA, Long Noncoding | 2022 |
N6-methyladenosine (m6A) regulator expression pattern correlates with the immune landscape in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adenosine; Humans; Lung Neoplasms; Tumor Microenvironment | 2022 |
Construction and validation of a nomogram based on N6-Methylandenosine-related lncRNAs for predicting the prognosis of non-small cell lung cancer patients.
Topics: Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Nomograms; Prognosis; RNA, Long Noncoding; Tumor Microenvironment | 2023 |
The prognostic value of N6-methyladenosine RBM15 regulators in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adenosine; Animals; Humans; Lung Neoplasms; Mammals; Prognosis; RNA-Binding Proteins; RNA, Messenger; RNA, Small Interfering | 2022 |
Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-κB axis.
Topics: Adenosine; Anesthetics; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; MicroRNAs; NF-kappa B; Propofol | 2022 |
N6-Methyladenosine Reader YTHDF2 Enhances Non-Small-Cell Lung Cancer Cell Proliferation and Metastasis through Mediating circ_SFMBT2 Degradation.
Topics: Adenosine; Carcinoma, Non-Small-Cell Lung; Cell Movement; Cell Proliferation; Humans; Lung Neoplasms; Protein Serine-Threonine Kinases; Repressor Proteins; RNA; RNA-Binding Proteins; Transcription Factors; Tumor Suppressor Proteins | 2022 |
A novel algorithm for lung adenocarcinoma based on N6 methyladenosine-related immune long noncoding RNAs as a reliable biomarker for predicting survival outcomes and selecting sensitive anti-tumor therapies.
Topics: Adenocarcinoma; Adenosine; Algorithms; Antineoplastic Agents; Humans; Lung; Lung Neoplasms; Prognosis; RNA, Long Noncoding; Tumor Microenvironment | 2022 |
Effects of N6-Methyladenosine Regulators on LAG3 and Immune Infiltrates in Lung Adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Antigens, CD; Humans; Lung Neoplasms; Lymphocyte Activation Gene 3 Protein; Prognosis; RNA-Binding Proteins; Tumor Microenvironment; Ubiquitin-Protein Ligases | 2022 |
N
Topics: Carcinoma, Non-Small-Cell Lung; HeLa Cells; Humans; Lung Neoplasms; Methyltransferases; Positive Transcriptional Elongation Factor B; RNA Polymerase II; RNA, Small Nuclear; Transcription, Genetic | 2023 |
Dissecting the m
Topics: A549 Cells; Adenosine; Afatinib; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Humans; Lung Neoplasms | 2020 |
ALKBH5-m
Topics: Adenocarcinoma of Lung; Adenosine; AlkB Homolog 5, RNA Demethylase; Animals; Cell Proliferation; Forkhead Box Protein M1; Humans; Hypoxia; Lung Neoplasms; Mice; Neoplasm Invasiveness; Signal Transduction | 2020 |
N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1.
Topics: Adenosine; Animals; Blood-Brain Barrier; Brain Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Epithelial-Mesenchymal Transition; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; MicroRNAs; Models, Biological; Neovascularization, Pathologic; RNA Interference; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2019 |
Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma.
Topics: Adenosine; Aged; AlkB Homolog 5, RNA Demethylase; Antineoplastic Agents, Immunological; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Datasets as Topic; Female; Gene Expression Regulation, Neoplastic; Heterogeneous-Nuclear Ribonucleoprotein Group C; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Male; Methylation; Methyltransferases; Middle Aged; Prognosis; RNA-Binding Proteins; RNA-Seq; T Follicular Helper Cells; Transcriptome | 2020 |
N
Topics: A549 Cells; Adenosine; AlkB Homolog 5, RNA Demethylase; Animals; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Disease Progression; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; RNA Stability; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-3 | 2020 |
N6-Methyladenosine Regulates the Expression and Secretion of TGFβ1 to Affect the Epithelial-Mesenchymal Transition of Cancer Cells.
Topics: 5' Untranslated Regions; Adenosine; Animals; Cell Movement; Down-Regulation; Epithelial-Mesenchymal Transition; Gene Knockdown Techniques; HeLa Cells; Humans; Lung Neoplasms; Methyltransferases; Mice; Peptide Chain Elongation, Translational; Protein Biosynthesis; Protein Stability; Snail Family Transcription Factors; Transforming Growth Factor beta1 | 2020 |
Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
Topics: Adenocarcinoma of Lung; Adenosine; Cohort Studies; Disease-Free Survival; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Prognosis; RNA, Messenger | 2020 |
Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA.
Topics: A549 Cells; Adenosine; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Enhancer of Zeste Homolog 2 Protein; Epithelial-Mesenchymal Transition; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lung Neoplasms; Methyltransferases; RNA, Messenger; Simvastatin; Tumor Cells, Cultured | 2020 |
KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
Topics: A549 Cells; Adenocarcinoma of Lung; Adenosine; Cell Movement; Cell Proliferation; Databases, Genetic; Female; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Methylation; Middle Aged; Mucin-3; Neoplasm Invasiveness; Neoplasm Staging; RNA Processing, Post-Transcriptional; RNA-Binding Proteins; Signal Transduction; Tumor Burden | 2021 |
Gene signatures of 6-methyladenine regulators in women with lung adenocarcinoma and development of a risk scoring system: a retrospective study using the cancer genome atlas database.
Topics: Adenocarcinoma of Lung; Adenosine; Databases, Genetic; DNA Copy Number Variations; Early Detection of Cancer; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Risk Assessment; RNA Processing, Post-Transcriptional; Survival Rate; Transcriptome | 2021 |
N
Topics: Adenosine; Animals; Apoptosis; Biomarkers, Tumor; Cell Nucleus; Cell Proliferation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Mice, Inbred NOD; Mice, SCID; RNA, Long Noncoding; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming.
Topics: Adenosine; Animals; Base Sequence; Cell Line, Tumor; Cell Polarity; Cell Proliferation; Cellular Reprogramming; Cytokines; Gene Deletion; Gene Expression Regulation; Lung Neoplasms; Macrophages; Melanoma, Experimental; Methylation; Methyltransferases; Mice, Knockout; Myeloid Cells; Neoplasm Metastasis; NF-kappa B; Programmed Cell Death 1 Receptor; Repressor Proteins; RNA-Binding Proteins; RNA, Neoplasm; STAT3 Transcription Factor; T-Lymphocytes, Regulatory; Tumor Microenvironment | 2021 |
METTL3-mediated m
Topics: Adenocarcinoma of Lung; Adenosine; Animals; Cell Line, Tumor; Cell Proliferation; F-Box-WD Repeat-Containing Protein 7; Heterografts; Humans; Lung Neoplasms; Methyltransferases; Mice; Mice, Inbred BALB C; Mice, Nude; RNA, Messenger | 2021 |
Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis.
Topics: Adenosine; Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cell Movement; Cell Proliferation; Cisplatin; DNA Methylation; Drug Resistance, Neoplasm; Epigenesis, Genetic; Exosomes; Ferroptosis; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Prognosis; S100 Calcium-Binding Protein A4; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.
Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; AMP-Activated Protein Kinase Kinases; Cell Line, Tumor; DNA Methylation; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mutation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins p21(ras); RNA, Messenger; Transfection | 2021 |
LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in lung cancer via binding with FUBP1 to activate c-MYC.
Topics: Adenosine; Animals; Carcinogenesis; Cell Line, Tumor; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice, Inbred BALB C; Neoplasm Invasiveness; Prognosis; Proto-Oncogene Proteins c-myc; RNA-Binding Proteins; RNA, Long Noncoding; Up-Regulation | 2021 |
Cigarette smoking induces aberrant N
Topics: A549 Cells; Adenosine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cigarette Smoking; Death-Associated Protein Kinases; Disease Progression; Down-Regulation; Gene Expression Regulation; HEK293 Cells; Humans; Lung Neoplasms; NF-kappa B; Nicotiana; Oncogenes; RNA, Messenger; Signal Transduction | 2021 |
Microarray analysis of genes with differential expression of m6A methylation in lung cancer.
Topics: Adenosine; Biomarkers, Tumor; DNA Methylation; Epigenome; Epigenomics; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Lung Neoplasms; Oligonucleotide Array Sequence Analysis; Transcriptome | 2021 |
Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
Topics: Adenocarcinoma of Lung; Adenosine; Biomarkers, Tumor; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Methylation; Prognosis; RNA Processing, Post-Transcriptional; Survival Rate; Transcriptome; Tumor Microenvironment | 2021 |
N
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Apoptosis; Arsenites; Cell Cycle Proteins; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Dose-Response Relationship, Drug; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; Lung; Lung Neoplasms; Methyltransferases; MicroRNAs; Nuclear Proteins; Phenotype; RNA Splicing Factors; Signal Transduction; Sodium Compounds; Time Factors | 2018 |
m
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Carcinoma, Squamous Cell; Cell Line, Tumor; Disease Progression; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Kruppel-Like Transcription Factors; Lung Neoplasms; Oncogenes; Prognosis; RNA Stability; RNA, Messenger; RNA, Neoplasm | 2018 |
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner.
Topics: Adenosine; Animals; Cell Line, Tumor; Disease-Free Survival; Female; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Lung Neoplasms; Male; Mice; MicroRNAs; Ovarian Neoplasms; RNA-Binding Proteins; Serum Response Factor; Xenograft Model Antitumor Assays | 2019 |
The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; RNA, Messenger; Ubiquitin-Specific Peptidase 7 | 2019 |